empty

MS

7 results found for: MS

‘Not enough evidence’ to recommend cannabis says NICE

NICE has decided not to recommend the use of cannabis-based medicines in severe treatment-resistant epilepsy.

Inflammation may contribute to depression

A new Canadian study reports that psychiatric conditions may emerge five years before the diagnosis of inflammatory diseases

MS drug improves survival

Beta-interferons produce “a significant survival advantage among people with relapsing-onset multiple sclerosis” (RRMS), according to a new study

Multiple sclerosis: an overview

This module is about multiple sclerosis and identifying the symptoms.

Getting to grips with cannabis-based medicines

The reclassification of cannabis-based medicines was a big story in 2018. Here we look at some questions following on from the move

Clinical briefing: A game changer for MS sufferers?

A new report raises the prospect that multiple sclerosis might soon be ‘preventable or functionally curable’

New MS campaign launches

Experts are encouraging people with multiple sclerosis to access vital health services through a new campaign.



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.